Search Results - Reva Basho
- Showing 1 - 7 results of 7
-
1
COVID-19 in cancer patients: risk, clinical features, and management by Cuiwei Liu, Yanxia Zhao, Derick Okwan‐Duodu, Reva Basho, Xiaojiang Cui
Published 2020Revisão -
2
Neoadjuvant HER2-targeted therapy with or without immunotherapy with pembrolizumab (neoHIP): An open label randomized phase II trial by Heather L. McArthur, J.H.S. Leal, David B. Page, Aditya Bardia, Laura M. Spring, Christina DiLauro Abaya, Reva Basho, Lindsey Ristow, Hannah Coleman, Stephen L. Shiao, Simon Knott, Mourad Tighiouart, Farnaz Dadmanesh, Sunil Verma, A. E. Giuliano
Published 2019Artigo -
3
Comparative Effectiveness of an mTOR-Based Systemic Therapy Regimen in Advanced, Metaplastic and Nonmetaplastic Triple-Negative Breast Cancer by Reva Basho, Clinton Yam, Michael Z. Gilcrease, Rashmi K. Murthy, Thorunn Helgason, Daniel D. Karp, Funda Meric‐Bernstam, Kenneth R. Hess, Vicente Valero, Constance T. Albarracin, Jennifer K. Litton, Mariana Chávez‐MacGregor, David S. Hong, Razelle Kurzrock, Gabriel N. Hortobágyi, Filip Janků, Stacy L. Moulder
Published 2018Artigo -
4
Survival Outcomes by <i>TP53</i> Mutation Status in Metastatic Breast Cancer by Funda Meric‐Bernstam, Xiaofeng Zheng, Maryam Shariati, Senthil Damodaran, Chetna Wathoo, Lauren Brusco, Mehmet Demirhan, Coya Tapia, Agda Karina Eterovic, Reva Basho, Naoto T. Ueno, Filip Janků, Ayşegül A. Şahin, Jordi Rodón, Russell Broaddus, Tae-Beom Kim, John Mendelsohn, Kenna Shaw, Debu Tripathy, Gordon B. Mills, Ken Chen
Published 2018Artigo -
5
Clinical outcomes based on multigene profiling in metastatic breast cancer patients. by Reva Basho, Débora De Melo Gagliato, Naoto T. Ueno, Ricardo H. Álvarez, Chetna Wathoo, Huiqin Chen, Caimiao Wei, Ayşegül A. Şahin, Sinchita Roy‐Chowdhuri, Stacy L. Moulder, Mariana Chavez-Mac Gregor, Jennifer K. Litton, Vicente Valero, Rajyalakshmi Luthra, Kenna Shaw, John Mendelsohn, Gordon B. Mills, Debu Tripathy, Funda Meric‐Bernstam
Published 2015Artigo -
6
Evaluating the impact of age on immune checkpoint therapy biomarkers by Rossin Erbe, Zheyu Wang, Sharon Wu, Joanne Xiu, Neeha Zaidi, Jennifer La, David Tuck, Nathanael R. Fillmore, Nicolás A. Giraldo, Michael J. Topper, Stephen B. Baylin, Marc E. Lippman, Claudine Isaacs, Reva Basho, Ilya G. Serebriiskii, Heinz‐Josef Lenz, Igor Astsaturov, John L. Marshall, Josephine A. Taverna, Jerry Lee, Elizabeth M. Jaffee, Evanthia T. Roussos Torres, Ashani T. Weeraratna, Hariharan Easwaran, Elana J. Fertig
Published 2021Artigo -
7
Standardized Definitions for Efficacy End Points in Neoadjuvant Breast Cancer Clinical Trials: NeoSTEEP by Jennifer K. Litton, Meredith M. Regan, Lajos Pusztai, Hope S. Rugo, Sara M. Tolaney, Elizabeth Garrett‐Mayer, Laleh Amiri‐Kordestani, Reva Basho, Ana F. Best, Jean-François Boileau, Carsten Denkert, Jared C. Foster, Nadia Harbeck, Heather A. Jacene, Tari A. King, Ginny Mason, Ciara C. O’Sullivan, Tatiana M. Prowell, Andrea L. Richardson, Karla A. Sepulveda, Mary Lou Smith, Judy A. Tjoe, Gulisa Turashvili, Wendy A. Woodward, Lynn Pearson Butler, Elena I. Schwartz, Larissa A. Korde
Published 2023Artigo
Search Tools:
Related Subjects
Cancer
Internal medicine
Medicine
Oncology
Breast cancer
Biology
Gene
Genetics
Immunotherapy
Metastatic breast cancer
Neoadjuvant therapy
Apoptosis
Bevacizumab
Biochemistry
Bioinformatics
Blockade
Cancer research
Chemistry
Chemotherapy
Clinical endpoint
Clinical trial
Coronavirus
Coronavirus disease 2019 (COVID-19)
DNA methylation
Disease
Environmental health
Everolimus
Gene expression
Immune checkpoint
Immune system